跳转至内容
Merck
CN
  • Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.

Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.

Oncotarget (2016-11-12)
Guodong Tang, Dingyang Liu, Gelei Xiao, Qing Liu, Jian Yuan
摘要

In this study, our findings indicated that FOXO1 expression frequently decreased in glioma tissues and cells. FOXO1 expression decrease correlated with glioma progression and predicted a worse overall survival of glioma patients. Restored FOXO1 expression inhibited glioma cells invasion and suppressed glioma cells proliferation in vitro and growth in vivo. Additionally, we found that KLF4 expression frequently increased in glioma tissues and negatively correlated with FOXO1 expression. Bioinformatics analysis and experimental results indicated that KLF4 transcriptionally repressed FOXO1 expression in glioma cells. Moreover, KLF4 expression increase correlated with glioma progression and predicted a poorer overall survival of glioma patients. KLF4 knockdown attenuated glioma cells invasion and growth. These data provide a rationale for targeted intervention on KLF4-FOXO1 signaling pathway to suppress glioma progression.

材料
货号
品牌
产品描述

Sigma-Aldrich
MISSION® esiRNA, targeting human KLF4